Table 5.
Associations Between VMS and Urinary NTX Level in Multivariable-Adjusted Modelsa
VMS any versus none: basic model | VMS frequent versus not frequent: basic modelb | |||||
---|---|---|---|---|---|---|
Menopausal stage | β coefficientc | SD | p Value | β coefficientd | SD | p Value |
Premenopausal | 1.017 | 0.809 | .17 | 0.741 | 1.436 | .61 |
Early perimenopausal | 1.944 | 0.486 | <.0001 | 3.077 | 0.675 | <.0001 |
Late perimenopausal | 2.437 | 1.011 | .03 | 3.625 | 1.069 | <.001 |
Postmenopausal | 1.259 | 0.769 | .10 | 1.909 | 0.799 | .02 |
VMS any versus none: model with FSHe | VMS frequent versus not frequent: model with FSH | |||||
---|---|---|---|---|---|---|
Menopausal stage | β coefficient | SD | p Value | β coefficient | SD | p Value |
Premenopausal | 0.802 | 0.805 | .32 | 0.391 | 1.430 | .78 |
Early perimenopausal | 1.347 | 0.486 | .006 | 2.024 | 0.676 | .003 |
Late perimenopausal | 1.071 | 1.107 | .33 | 2.519 | 1.073 | .02 |
Postmenopausal | 0.546 | 0.769 | .48 | 0.919 | 0.801 | .25 |
VMS any versusnone: model with estradiolf | VMS frequent versus not frequent: model with estradiol | |||||
---|---|---|---|---|---|---|
Menopausal stage | β coefficient | SD | p Value | β coefficient | SD | p Value |
Premenopausal | 0.969 | 0.812 | .23 | 0.701 | 1.442 | .63 |
Early perimenopausal | 1.784 | 0.489 | <.001 | 2.827 | 0.679 | <.0001 |
Late perimenopausal | 2.022 | 1.113 | .07 | 3.294 | 1.079 | .002 |
Postmenopausal | 1.307 | 0.774 | .09 | 1.748 | 0.805 | .06 |
VMS any versus none: model with FSH and estradiolg | VMS frequent versus not frequent: model with FSH and estradiol | |||||
---|---|---|---|---|---|---|
Menopausal stage | β coefficient | SD | p Value | β coefficient | SD | p Value |
Premenopausal | 0.787 | 0.805 | .33 | 0.443 | 1.430 | .76 |
Early perimenopausal | 1.336 | 0.486 | .006 | 1.022 | 0.676 | .003 |
Late perimenopausal | 1.042 | 1.107 | .35 | 2.492 | 1.073 | .02 |
Postmenopausal | 0.557 | 0.769 | .47 | 0.930 | 0.801 | .25 |
Repeated-measures models adjusted for age, smoking, BMI, race/ethnicity, calcium and vitamin D supplement intake, physical activity score (log-transformed), alcohol intake (kcal/d, log-transformed), and study site.
“Frequent VMS” indicates VMS frequency ≥ 5 days in the past 2 weeks; “Not frequent VMS” indicates VMS frequency < 5 days in the past 2 weeks.
β coefficient represents the increment in urinary NTX (nM BCE/mM of creatinine) associated with reporting any VMS versus no VMS.
β coefficient represents the increment in urinary NTX (nM BCE/mM of creatinine) comparing frequent VMS with not frequent VMS.
Includes variables of basic model, follicle-stimulating hormone level (FSH, IU/L) and menstrual cycle phase (follicular versus not follicular or unknown phase).
Repeated-measures models adjusted for variables of the basic model, serum estradiol concentration (pg/mL), and menstrual cycle phase.
Repeated-measures models adjusted for variables of the basic model, serum FSH level, serum estradiol concentration, and menstrual cycle phase.